A hyperbranched dopamine-containing PEG-based polymer for the inhibition of α-synuclein fibrillation

Biochemical and Biophysical Research Communications

Volumn 469, Issue 4, 2016, Pages 830-835

  Breydo, Leonid ^a   Newland, Ben ^b,c   Zhang, Hong ^d   Rosser, Anne ^c   Werner, Carsten ^b   Uversky, Vladimir N ^a,e,f   Wang, Wenxin ^d,g  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b LEIBNIZ INSTITUTE OF POLYMER RESEARCH DRESDEN   (Germany)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

^e INSTITUTE FOR BIOLOGICAL INSTRUMENTATION   (Russian Federation)

^f KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^g TIANJIN UNIVERSITY   (China)

Author keywords

Dopamine; Hyperbranched polymers; Macromolecular crowding; Parkinson's disease; Protein aggregation; RAFT polymerization; synuclein

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; MACROGOL; AMYLOID; MACROGOL DERIVATIVE; PROTEIN BINDING;

ARTICLE; ATOM TRANSFER RADICAL POLYMERIZATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; MACROMOLECULAR CROWDING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN UNFOLDING; CHEMISTRY; DIMERIZATION; DRUG FORMULATION; PROCEDURES; SYNTHESIS;

ALPHA-SYNUCLEIN; AMYLOID; DIMERIZATION; DOPAMINE; DRUG COMPOUNDING; POLYETHYLENE GLYCOLS; PROTEIN BINDING;

EID: 84957582752     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.12.060     Document Type: Article

References (45)

1. J.J. Zarranz, J. Alegre, J.C. Gomez-Esteban, E. Lezcano, R. Ros, I. Ampuero, L. Vidal, J. Hoenicka, O. Rodriguez, B. Atares, V. Llorens, E. Gomez Tortosa, T. del Ser, D.G. Munoz, and J.G. de Yebenes The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia Ann. Neurol. 55 2004 164 173
2. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E.S. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W.G. Johnson, A.M. Lazzarini, R.C. Duvoisin, G. Di Iorio, L.I. Golbe, and R.L. Nussbaum Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
3. R. Kruger, W. Kuhn, T. Muller, D. Woitalla, M. Graeber, S. Kosel, H. Przuntek, J.T. Epplen, L. Schols, and O. Riess Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nat. Genet. 18 1998 106 108
4. S. Petrucci, M. Ginevrino, and E.M. Valente Phenotypic spectrum of alpha-synuclein mutations: new insights from patients and cellular models Park. Relat. Disord. 22 2016 S16 S20
5. A. Singleton, K. Gwinn-Hardy, Y. Sharabi, S.T. Li, C. Holmes, R. Dendi, J. Hardy, A. Crawley, and D.S. Goldstein Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication Brain 127 2004 768 772
6. A.B. Singleton, M. Farrer, J. Johnson, A. Singleton, S. Hague, J. Kachergus, M. Hulihan, T. Peuralinna, A. Dutra, R. Nussbaum, S. Lincoln, A. Crawley, M. Hanson, D. Maraganore, C. Adler, M.R. Cookson, M. Muenter, M. Baptista, D. Miller, J. Blancato, J. Hardy, and K. Gwinn-Hardy Alpha-synuclein locus triplication causes Parkinson's disease Science 302 2003 841
7. M. Farrer, J. Kachergus, L. Forno, S. Lincoln, D.S. Wang, M. Hulihan, D. Maraganore, K. Gwinn-Hardy, Z. Wszolek, D. Dickson, and J.W. Langston Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications Ann. Neurol. 55 2004 174 179
8. M.G. Spillantini, M.L. Schmidt, V.M. Lee, J.Q. Trojanowski, R. Jakes, and M. Goedert Alpha-synuclein in Lewy bodies Nature 388 1997 839 840
9. M. Goedert Alpha-synuclein and neurodegenerative diseases Nat. Rev. Neurosci. 2 2001 492 501
10. K.K. Dev, K. Hofele, S. Barbieri, V.L. Buchman, and H. van der Putten Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease Neuropharmacology 45 2003 14 44
11. A.L. Fink The aggregation and fibrillation of alpha-synuclein Acc. Chem. Res. 39 2006 628 634
12. M. Baba, S. Nakajo, P.H. Tu, T. Tomita, K. Nakaya, V.M. Lee, J.Q. Trojanowski, and T. Iwatsubo Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies Am. J. Pathol. 152 1998 879 884
13. L. Breydo, J.W. Wu, and V.N. Uversky Alpha-synuclein misfolding and Parkinson's disease Biochim. Biophys. Acta. 1822 2012 261 285
14. K.A. Conway, J.D. Harper, and P.T. Lansbury Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease Nat. Med. 4 1998 1318 1320
15. O.M. El-Agnaf, R. Jakes, M.D. Curran, D. Middleton, R. Ingenito, E. Bianchi, A. Pessi, D. Neill, and A. Wallace Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments FEBS Lett. 440 1998 71 75
16. J.-S. Choi, H.J. Choi, D.C. Jung, J.-H. Lee, and J. Cheon Nanoparticle assisted magnetic resonance imaging of the early reversible stages of amyloid [small beta] self-assembly Chem. Commun. 2008 2197 2199
17. N.G. Bastus, M.J. Kogan, R. Amigo, D. Grillo-Bosch, E. Araya, A. Turiel, A. Labarta, E. Giralt, and V.F. Puntes Gold nanoparticles for selective and remote heating of β-amyloid protein aggregates Mater. Sci. Eng. C 27 2007 1236 1240
18. S. Linse, C. Cabaleiro-Lago, W.-F. Xue, I. Lynch, S. Lindman, E. Thulin, S.E. Radford, and K.A. Dawson Nucleation of protein fibrillation by nanoparticles Proc. Natl. Acad. Sci. U. S. A 104 2007 8691 8696
19. O.G. Jones, and R. Mezzenga Inhibiting, promoting, and preserving stability of functional protein fibrils Soft. Matter. 8 2012 876 895
20. M. Zaman, E. Ahmad, A. Qadeer, G. Rabbani, and R.H. Khan Nanoparticles in relation to peptide and protein aggregation Int. J. nanomedicine 9 2014 899
21. J. Goers, V.N. Uversky, and A.L. Fink Polycation-induced oligomerization and accelerated fibrillation of human α-synuclein in vitro Protein Sci. 12 2003 702 707
22. C. Cabaleiro-Lago, F. Quinlan-Pluck, I. Lynch, S. Lindman, A.M. Minogue, E. Thulin, D.M. Walsh, K.A. Dawson, and S. Linse Inhibition of amyloid β protein fibrillation by polymeric nanoparticles J. Am. Chem. Soc. 130 2008 15437 15443
23. S. Beg, A. Samad, M.I. Alam, and I. Nazish Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain CNS Neurol. Disord. Drug Targets (Former. Curr. Drug Targets-CNS Neurol. Disord.) 10 2011 576 588
24. B. Newland, E. Dowd, and A. Pandit Biomaterial approaches to gene therapies for neurodegenerative disorders of the CNS Biomater. Sci. 1 2013 556 576
25. B. Newland, H. Newland, C. Werner, A. Rosser, and W.X. Wang Prospects for polymer therapeutics in Parkinson's disease and other neurodegenerative disorders Prog. Polym. Sci. 44 2015 79 112
26. T. Zhao, Y. Zheng, J. Poly, and W. Wang Controlled multi-vinyl monomer homopolymerization through vinyl oligomer combination as a universal approach to hyperbranched architectures Nat. Commun. 4 2013 1873
27. Y. Zheng, H. Cao, B. Newland, Y. Dong, A. Pandit, and W. Wang 3D single cyclized polymer chain structure from controlled polymerization of multi-vinyl monomers: beyond Flory-Stockmayer theory J. Am. Chem. Soc. 133 2011 13130 13137
28. Y. Zheng, B. Newland, H. Tai, A. Pandit, and W. Wang Single cyclized molecule structures from RAFT homopolymerization of multi-vinyl monomers Chem. Commun. 48 2012 3085 3087
29. H. Lee, B.P. Lee, and P.B. Messersmith A reversible wet/dry adhesive inspired by mussels and geckos Nature 448 2007 338 341
30. H. Zhang, T. Zhao, B. Newland, P. Duffy, A.N. Annaidh, E.D. O'Cearbhaill, and W. Wang On-demand and negative-thermo-swelling tissue adhesive based on highly branched ambivalent PEG-catechol copolymers J. Mat. Chem. B 3 2015 6420 6428
31. M. Monaghan, U. Greiser, H. Cao, W. Wang, and A. Pandit An antibody fragment functionalized dendritic PEGylated poly(2-(dimethylamino)ethyl diacrylate) as a vehicle of exogenous microRNA Drug Deliv. Transl. Res. 2 2012 406 414
32. M.S. Planchard, S.E. Exley, S.E. Morgan, and V. Rangachari Dopamine-induced alpha-synuclein oligomers show self- and cross-propagation properties Protein Sci. 23 2014 1369 1379
33. S.L. Leong, M.G. Hinds, A.R. Connor, D.P. Smith, E. Illes-Toth, C.L. Pham, K.J. Barnham, and R. Cappai The N-terminal residues 43 to 60 form the interface for dopamine mediated alpha-synuclein dimerisation PLoS One 10 2015 e0116497
34. K.A. Conway, J.C. Rochet, R.M. Bieganski, and P.T. Lansbury Jr. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct Science 294 2001 1346 1349
35. R. Cappai, S.L. Leck, D.J. Tew, N.A. Williamson, D.P. Smith, D. Galatis, R.A. Sharples, C.C. Curtain, F.E. Ali, R.A. Cherny, J.G. Culvenor, S.P. Bottomley, C.L. Masters, K.J. Barnham, and A.F. Hill Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway FASEB J. 19 2005 1377 1379
36. A.F. Fischer, and K.M. Matera Stabilization of alpha-synuclein oligomers in vitro by the neurotransmitters, dopamine and norepinephrine: the effect of oxidized catecholamines Neurochem. Res. 40 2015 1341 1349
37. S.L. Leong, R. Cappai, K.J. Barnham, and C.L. Pham Modulation of alpha-synuclein aggregation by dopamine: a review Neurochem. Res. 34 2009 1838 1846
38. S.L. Leong, C.L. Pham, D. Galatis, M.T. Fodero-Tavoletti, K. Perez, A.F. Hill, C.L. Masters, F.E. Ali, K.J. Barnham, and R. Cappai Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation Free Radic. Biol. Med. 46 2009 1328 1337
39. M. Bisaglia, L. Tosatto, F. Munari, I. Tessari, P.P. de Laureto, S. Mammi, and L. Bubacco Dopamine quinones interact with alpha-synuclein to form unstructured adducts Biochem. Biophys. Res. Commun. 394 2010 424 428
40. L. Breydo, K.D. Reddy, A. Piai, I.C. Felli, R. Pierattelli, and V.N. Uversky The crowd you're in with: effects of different types of crowding agents on protein aggregation Biochim. Biophys. Acta. 1844 2014 346 357
41. L.A. Munishkina, E.M. Cooper, V.N. Uversky, and A.L. Fink The effect of macromolecular crowding on protein aggregation and amyloid fibril formation J. Mol. Recognit. 17 2004 456 464
42. L.A. Munishkina, A. Ahmad, A.L. Fink, and V.N. Uversky Guiding protein aggregation with macromolecular crowding Biochemistry 47 2008 8993 9006
43. F.E. Herrera, A. Chesi, K.E. Paleologou, A. Schmid, A. Munoz, M. Vendruscolo, S. Gustincich, H.A. Lashuel, and P. Carloni Inhibition of alpha-synuclein fibrillization by dopamine is mediated by interactions with five C-terminal residues and with E83 in the NAC region PLOS One 3 2008 e3394
44. A. Rekas, R.B. Knott, A. Sokolova, K.J. Barnham, K.A. Perez, C.L. Masters, S.C. Drew, R. Cappai, C.C. Curtain, and C.L. Pham The structure of dopamine induced alpha-synuclein oligomers Eur. Biophys. J. 39 2010 1407 1419
45. H.J. Lee, S.M. Baek, D.H. Ho, J.E. Suk, E.D. Cho, and S.J. Lee Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers Exp. Mol. Med. 43 2011 216 222